The DOI matches its Crossref record; 914 of the 914 references it cites were found in a registry or an index.
Human prostate cancer risk factors
Open accessAbstract
Prostate cancer has the highest prevalence of any nonskin cancer in the human body, with similar likelihood of neoplastic foci found within the prostates of men around the world regardless of diet, occupation, lifestyle, or other factors. Essentially all men with circulating androgens will develop microscopic prostate cancer if they live long enough. This review is a contemporary and comprehensive, literature-based analysis of the putative risk factors for human prostate cancer, and the results were presented at a multidisciplinary consensus conference held in Crystal City, Virginia, in the fall of 2002. The objectives were to evaluate known environmental factors and mechanisms of prostatic carcinogenesis and to identify existing data gaps and future research needs. The review is divided into four sections, including 1) epidemiology (endogenous factors [family history, hormones, race, aging and oxidative stress] and exogenous factors [diet, environmental agents, occupation and other factors, including lifestyle factors]); 2) animal and cell culture models for prediction of human risk (rodent models, transgenic models, mouse reconstitution models, severe combined immunodeficiency syndrome mouse models, canine models, xenograft models, and cell culture models); 3) biomarkers in prostate cancer, most of which have been tested only as predictive factors for patient outcome after treatment rather than as risk factors; and 4) genotoxic and nongenotoxic mechanisms of carcinogenesis. The authors conclude that most of the data regarding risk relies, of necessity, on epidemiologic studies, but animal and cell culture models offer promise in confirming some important findings. The current understanding of biomarkers of disease and risk factors is limited. An understanding of the risk factors for prostate cancer has practical importance for public health research and policy, genetic and nutritional education and chemoprevention, and prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Moll, R., Franke, W. W., Schiller, D. L., Geiger, B., & Krepler, R. (1982) · Cell · doi:10.1016/0092-8674(82)90400-7 · Cited by 5,247
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Developmental effects of endocrine-disrupting chemicals in wildlife and humans.
Colborn, T., vom Saal, F. S., & Soto, A. M. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.93101378 · Cited by 3,445
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Oxidative Stress, Caloric Restriction, and Aging
Sohal, R. S., & Weindruch, R. (1996) · Science · doi:10.1126/science.273.5271.59 · Cited by 3,131
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
Boise, L. H., González-García, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G., & Thompson, C. B. (1993) · Cell · doi:10.1016/0092-8674(93)90508-n · Cited by 3,087
Matrix Metalloproteinases: A Review
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., & Engler, J. A. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040020401 · Cited by 2,970
Dietary Carcinogens and Anticarcinogens: Oxygen radicals and degenerative diseases
Ames, B. N. (1983) · Science · doi:10.1126/science.6351251 · Cited by 2,969
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Clark, L. (1996) · JAMA · doi:10.1001/jama.276.24.1957 · Cited by 2,719
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Stadtman, E. R. (1992) · Science · doi:10.1126/science.1355616 · Cited by 2,697
Prooxidant States and Tumor Promotion
Cerutti, P. A. (1985) · Science · doi:10.1126/science.2981433 · Cited by 2,497
Mechanisms and Genes of Cellular Suicide
Steller, H. (1995) · Science · doi:10.1126/science.7878463 · Cited by 2,479
Lycopene as the most efficient biological carotenoid singlet oxygen quencher
Di Mascio, P., Kaiser, S., & Sies, H. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90467-0 · Cited by 2,231
A severe combined immunodeficiency mutation in the mouse
Bosma, G. C., Custer, R. P., & Bosma, M. J. (1983) · Nature · doi:10.1038/301527a0 · Cited by 2,207
Armstrong, B., & Doll, R. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910150411 · Cited by 2,151
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn, M. E., Ks, N., Ohnuki, Y., Lechner, J. F., & Jones, L. W. (1979) · PubMed · Cited by 2,123
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Hamer, D. H. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.004405 · Cited by 1,800
LNCaP model of human prostatic carcinoma.
Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H. E., Chu, T. M., MIRAND, E. A., & Murphy, G. P. (1983) · PubMed · Cited by 1,789
Soto, A. M., Sonnenschein, C., Chung, K. L., Fernandez, M. F., Olea, N., & Serrano, F. O. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s7113 · Cited by 1,720
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner, N., Carroll, P. R., Flax, J. D., Blumenfeld, W., & Folkman, J. (1993) · PubMed Central · Cited by 1,620
Cattoretti, G., Becker, M. H. G., Key, G., Duchrow, M., Schlüuter, C., Galle, J., & Gerdes, J. (1992) · The Journal of Pathology · doi:10.1002/path.1711680404 · Cited by 1,447
Mortality in relation to smoking : 40 years' observations on male British doctors
Doll, H. (1994) · Medical Entomology and Zoology · Cited by 1,417
Intake of Carotenoids and Retino in Relation to Risk of Prostate Cancer
Giovannucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colditz, G. A., & Willett, W. C. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.23.1767 · Cited by 1,320
CADHERINS: A MOLECULAR FAMILY IMPORTANT IN SELECTIVE CELL-CELL ADHESION
Takeichi, M. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.001321 · Cited by 1,306
Prostate cancer in a transgenic mouse.
Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., & Rosen, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3439 · Cited by 1,294
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.6961 · Cited by 1,252
Prognostic Factors in Prostate Cancer: College of American Pathologists Consensus Statement 1999
Bostwick, D. G., Grignon, D. J., Hammond, M. E. H., Amin, M. B., Cohen, M., Crawford, D., Gospadarowicz, M., Kaplan, R. S., Miller, D. S., Montironi, R., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0995-pfipc · Cited by 1,239
Self-citationOesterling, J. E. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)38491-4 · Cited by 1,230
Chamberlain, N. L., Driver, E. D., & Miesfeld, R. L. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.3181 · Cited by 1,156
(1968) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/40.1.43 · Cited by 1,108
STRUCTURE AND FUNCTION OF THE MANNOSE 6-PHOSPHATE/INSULINLIKE GROWTH FACTOR II RECEPTORS
Kornfeld, S. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.001515 · Cited by 1,092
Krajewski, S., Tanaka, S., Takayama, S., Schibler, M. J., Fenton, W. A., & Reed, J. C. (1993) · PubMed · Cited by 1,030
Boring, C. C., Squires, T. S., & Tong, T. (1993) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.43.1.7 · Cited by 966
FcR γ chain deletion results in pleiotrophic effector cell defects
Takai, T., Li, M., Sylvestre, D., Clynes, R., & Ravetch, J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90115-5 · Cited by 951
Molecular Biology of the Androgen Receptor
Gelmann, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.018 · Cited by 942
Isolation of a human prostate carcinoma cell line (DU 145)
Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., & Paulson, D. F. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910210305 · Cited by 926
Heinonen, O. P., Koss, L., Albanes, D., Taylor, P. R., Hartman, A. M., Edwards, B. K., Virtamo, J., Huttunen, J. K., Haapakoski, J., Malila, N., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.6.440 · Cited by 918
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County
Shimizu, H., Ross, R., Bernstein, L., Yatani, R., Henderson, B., & Mack, T. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.210 · Cited by 890
A Prospective Study of Tomato Products, Lycopene, and Prostate Cancer Risk
Giovannucci, E. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.5.391 · Cited by 882
The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Brufsky, A., Talcott, J., Hennekens, C. H., & Kantoff, P. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3320 · Cited by 873
Fine, H. A., Dear, K. B. G., Loeffler, J. S., Black, P. M., & Canellos, G. P. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2574::aid-cncr2820710823>3.0.co;2-1 · Cited by 861
Carotenoid content of fruits and vegetables: An evaluation of analytic data
Mangels, A. R., Holden, J. M., Beecher, G. R., Forman, M. R., & Lanza, E. (1993) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(93)91553-3 · Cited by 847
International trends and patterns of prostate cancer incidence and mortality
Hsing, A. W., Tsao, L., & Devesa, S. S. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000101)85:1<60::aid-ijc11>3.0.co;2-b · Cited by 846
Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., & Nelson, W. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11733 · Cited by 838
Tuxhorn, J. A., Ayala, G. E., Smith, M. J., Smith, V. C., Dang, T. D., & Rowley, D. R. (2002) · PubMed · Cited by 783
A Prospective Study of Dietary Fat and Risk of Prostate Cancer
Giovannucci, E., Rimm, E. B., Colditz, G. A., Stampfer, M. J., Ascherio, A., Chute, C. C., & Willett, W. C. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.19.1571 · Cited by 773
KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2
Dong, J.-T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., & Barrett, J. C. (1995) · Science · doi:10.1126/science.7754374 · Cited by 757
Sandgren, E. P., Luetteke, N. C., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1990) · Cell · doi:10.1016/0092-8674(90)90075-p · Cited by 752
The SCID Mouse Mutant: Definition, Characterization, and Potential Uses
Bosma, M. J., & Carroll, A. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001543 · Cited by 748
Koivisto, P. A., Kononen, J., Palmberg, C., Tammela, T. L. J., HYYTINEN, E.-R., Isola, J. J., Trapman, J., Cleutjens, K. B. J. M., Noordzij, M. A., Visakorpi, T., et al. (1997) · PubMed · Cited by 728
Thalmann, G. N., Anezinis, P., Chang, S., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pathak, S., von Eschenbach, A. C., & Chung, L. W. K. (1994) · PubMed · Cited by 727
Family history and the risk of prostate cancer
Steinberg, G. D., Carter, B. S., Beaty, T. H., Childs, B., & Walsh, P. C. (1990) · The Prostate · doi:10.1002/pros.2990170409 · Cited by 718
Endogenous mutagens and the causes of aging and cancer
Ames, B. N., & Gold, L. S. (1991) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(91)90157-j · Cited by 715
Fruit and Vegetable Intakes and Prostate Cancer Risk
Cohen, J. H., Kristal, A. R., & Stanford, J. L. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.1.61 · Cited by 709
Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
Reiter, R. E., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le Beau, M. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1735 · Cited by 673
Whittemore, A. S., Kolonel, L. N., Wu, A. H., John, E. M., Gallagher, R. P., Howe, G. R., Burch, J. D., Hankin, J., Dreon, D. M., West, D. W., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.9.652 · Cited by 665
Gann, P. H., Ma, J., Giovannucci, E. L., Willett, W. C., Sacks, F. M., Hennekens, C. H., & Stampfer, M. J. (1999) · PubMed · Cited by 656
Hanchette, C. L., & Schwartz, G. G. (1992) · Cancer · doi:10.1002/1097-0142(19921215)70:12<2861::aid-cncr2820701224>3.0.co;2-g · Cited by 645
Epidemiological studies on brassica vegetables and cancer risk.
Verhoeven, D. T. H., Goldbohm, R. A., van Poppel, G. A. F. C., Verhagen, H., & van den Brandt, P. A. (1996) · PubMed · Cited by 645
Severson, R. K., Nomura, A. M., Grove, J., & Stemmermann, G. N. (1989) · PubMed · Cited by 614
Hereditary Prostate Cancer: Epidemiologic and Clinical Features
Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B., & Walsh, P. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35617-3 · Cited by 612
Endogenous hormones as a major factor in human cancer.
Henderson, B. E., Ross, R. K., Pike, M. C., & Casagrande, J. T. (1982) · PubMed · Cited by 602
Metastatic prostate cancer in a transgenic mouse.
Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., & Greenberg, N. M. (1996) · PubMed · Cited by 599
Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.
Taplin, M., Bubley, G. J., Ko, Y., Small, E. J., Upton, M. P., Rajeshkumar, B. R., & Balk, S. P. (1999) · PubMed · Cited by 596
Colombel, M. C., Symmans, W. F., de Medina, S. G. D., O’Toole, K., Chopin, D. K., Benson, M. C., Olsson, C. A., Korsmeyer, S. J., & Buttyan, R. (1993) · PubMed · Cited by 591
Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene
Bookstein, R., Shew, J.-Y., Chen, P.-L., Scully, P., & Lee, W.-H. (1990) · Science · doi:10.1126/science.2300823 · Cited by 591
Soybean Phytoestrogen Intake and Cancer Risk
Herman, C., Adlercreutz, T., Goldin, B. R., Gorbach, S. L., HÖckerstedt, K. A. V., Watanabe, S., HÃmÃlÃinen, E. K., Markkanen, M. H., MÃkelÃ, T. H., WÃhÃlÃ, K. T., et al. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.3_suppl.757s · Cited by 590
Breslow, N., Chan, C. W., Dhom, G., Drury, R. A. B., Franks, L. M., Gellei, B., Lee, Y. S., Lundberg, S., Sparke, B., Sternbya, N. H., et al. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910200506 · Cited by 584
Intraductal dysplasia: A premalignant lesion of the prostate
McNeal, J. E., & Bostwick, D. G. (1986) · Human Pathology · doi:10.1016/s0046-8177(86)80156-3 · Cited by 573
Self-citationHsp104 is required for tolerance to many forms of stress.
Sanchez, Y., Taulien, J., Borkovich, K. A., & Lindquist, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05295.x · Cited by 564
PREDIAGNOSTIC SERUM SELENIUM AND RISK OF CANCER
Willett, W., Steven Morris, J., Pressel, S., Taylor, J., Frank Polk, B., Stampfer, M., Rosner, B., Schneider, K., & Hames, C. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90116-2 · Cited by 548
Raffo, A. J., Perlman, H., Chen, M., Day, M. L., Streitman, J., & Buttyan, R. (1995) · PubMed · Cited by 542
Study of Prediagnostic Selenium Level in Toenails and the Risk of Advanced Prostate Cancer
Yoshizawa, K., Willett, W. C., Morris, S. J., Stampfer, M. J., Spiegelman, D., Rimm, E. B., & Giovannucci, E. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.16.1219 · Cited by 536
Insulin-like growth factors and cancer
Fürstenberger, G., & Senn, H.-J. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00731-3 · Cited by 536
Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).
Schwartz, G. G., & Hulka, B. S. (1990) · PubMed · Cited by 508
Influence of the Vitamin D-binding Protein on the Serum Concentration of 1,25-Dihydroxyvitamin D3
Bouillon, R., Van Assche, F. A., Van Baelen, H., Heyns, W., & De Moor, P. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110072 · Cited by 507
Cancer Incidence in Five Continents. Comparability and quality of data.
Dm, P., & Cs, M. (1992) · PubMed · Cited by 505
Three limitations of the body mass index
Garn, S., Leonard, W., & Hawthorne, V. (1986) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/44.6.996 · Cited by 499
Cohen, P. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1046 · Cited by 497
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males
Ross, R. K., Bernstein, L., Pike, M. C., Henderson, B. E., Lobo, R. A., Stanczyk, F. Z., & Shimizu, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)90927-u · Cited by 495
Risk Factors for Prostate Cancer
Pienta, K. J., & Esper, P. S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-10-199305150-00007 · Cited by 490
Foster, B. A., Gingrich, J. R., Kwon, E. D., Madias, C. A., & Greenberg, N. M. (1997) · PubMed · Cited by 489
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols
Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S., & Mukhtar, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171326098 · Cited by 486
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi, T., Kallioniemi, A. H., Syvänen, A. C., HYYTINEN, E.-R., Karhu, R., Tammela, T. L. J., Isola, J. J., & Kallioniemi, O. (1995) · PubMed · Cited by 480
p53 Protein Accumulation and Gene Mutation in the Progression of Human Prostate Carcinoma
Navone, N. M., Troncoso, P., Pisters, L. L., Goodrow, T. L., Palmer, J. L., Nichols, W. W., Eschenbach, A. C. V., & Conti, C. J. (1993) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/85.20.1657 · Cited by 478
Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study.
Kolonel, L. N., Hankin, J. H., Whittemore, A. S., Wu, A. H., Gallagher, R. P., Wilkens, L. R., John, E. M., Howe, G. R., Dreon, D. M., West, D. W., et al. (2000) · PubMed · Cited by 477
Lorenzo, G. D., Tortora, G., D’Armiento, F. P., Rosa, G. D., Staibano, S., Riccardo Autorino, B., D’Armiento, M., Laurentiis, M. D., Placido, S. D., Catalano, G., et al. (2002) · PubMed · Cited by 474
Allelic loss of chromosomes 16q and 10q in human prostate cancer.
Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I., & Isaacs, W. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8751 · Cited by 457
Naturally occurring oestrogens in foods—A review
Price, K. R., & Fenwick, G. R. (1985) · Food Additives & Contaminants · doi:10.1080/02652038509373531 · Cited by 448
Jenkins, R. B., Qian, J., Lieber, M. M., & Bostwick, D. G. (1997) · PubMed · Cited by 443
Self-citationHormone-Induced Morphogenesis and Growth: Role of Mesenchymal–Epithelial Interactions
CUNHA, G. R., CHUNG, L. W. K., SHANNON, J. M., TAGUCHI, O., & FUJII, H. (1983) · Proceedings of the 1982 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571139-5.50018-5 · Cited by 442
Geiger, B., & Ayalon, O. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.001515 · Cited by 442
Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study
Hoffman, R. M., Gilliland, F. D., Eley, J. W., Harlan, L. C., Stephenson, R. A., Stanford, J. L., Albertson, P. C., Hamilton, A. S., Hunt, W. C., & Potosky, A. L. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.5.388 · Cited by 441
Bello, D. (1997) · Carcinogenesis · doi:10.1093/carcin/18.6.1215 · Cited by 438
cis-trans lycopene isomers, carotenoids, and retinol in the human prostate.
Clinton, S. K., Emenhiser, C., Schwartz, S. J., Bostwick, D. G., Williams, A. W., Moore, B. J., & Erdman, J. W. (1996) · PubMed · Cited by 437
Self-citationChan, J. M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.14.1099 · Cited by 433
Cadherin switching in human prostate cancer progression.
Tomita, K., van Bokhoven, A., van Leenders, G. J. L. H., Ruijter, E. T. G., Jansen, C. F. J., Bussemakers, M. J. G., & Schalken, J. A. (2000) · PubMed · Cited by 425
Use of Agricultural Pesticides and Prostate Cancer Risk in the Agricultural Health Study Cohort
Alavanja, M. C. R. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg040 · Cited by 425
Recent Cancer Trends in the United States
Devesa, S. S., Blot, W. J., Stone, B. J., Miller, B. A., Tarone, R. E., & Fraumeni, J. F. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.3.175 · Cited by 420
Isaacs, J. T., Isaacs, W. B., Feitz, W. F. J., & Scheres, J. (1986) · The Prostate · doi:10.1002/pros.2990090306 · Cited by 407
Zinc, copper and selenium in reproduction
Bedwal, R. S., & Bahuguna, A. (1994) · Experientia · doi:10.1007/bf01952862 · Cited by 405
Yan, G., Fukabori, Y., McBride, G., Nikolaropolous, S., & McKeehan, W. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4513 · Cited by 403
Serum testosterone levels in healthy young black and white men.
Ross, R. K., Bernstein, L., Judd, H. L., Hanisch, R., Pike, M. C., & Henderson, B. E. (1986) · PubMed · Cited by 399
Klein, K. A., Reiter, R. E., Redula, J., Moradi, H., Zhu, X. L., Brothman, A. R., Lamb, D. J., Marcelli, M., Belldegrun, A., Witte, O. N., et al. (1997) · Nature Medicine · doi:10.1038/nm0497-402 · Cited by 399
Her-2-neu Expression and Progression Toward Androgen Independence in Human Prostate Cancer
Signoretti, S. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1918 · Cited by 397
Tilley, W. D., Buchanan, G., Hickey, T. E., & Bentel, J. M. (1996) · PubMed · Cited by 396
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
Kwon, E. D., Hurwitz, A. A., Foster, B. A., Madias, C., Feldhaus, A. L., Greenberg, N. M., Burg, M. B., & Allison, J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8099 · Cited by 394
Cancer incidence and mortality, 1973-1995: A report card for the U.�S.
Wingo, P. A., Ries, L. A. �., Rosenberg, H. M., Miller, D. S., & Edwards, B. K. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980315)82:6<1197::aid-cncr26>3.0.co;2-0 · Cited by 392
Shirai, T., Sano, M. E. B., Tamano, S., Takahashi, S., Hirose, M., Futakuchi, M., Hasegawa, R., Imaida, K., Matsumoto, K., Wakabayashi, K., et al. (1997) · PubMed · Cited by 392
Telomerase activity: a prevalent marker of malignant human prostate tissue.
Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., Shay, J. W., & Coffey, D. S. (1996) · PubMed · Cited by 391
Cher, M. L., Bova, G. S., Moore, D. H., Small, E. J., Carroll, P. R., Pin, S. S., Epstein, J. I., Isaacs, W. B., & Jensen, R. H. (1996) · PubMed · Cited by 391
Di Sant'Agnese, P. A. (1992) · Cancer · doi:10.1002/1097-0142(19920701)70:1+<254::aid-cncr2820701312>3.0.co;2-e · Cited by 387
Ueda, T., Bruchovsky, N., & Sadar, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108255200 · Cited by 381
Albanes, D., Heinonen, O., Huttunen, J., Taylor, P., Virtamo, J., Edwards, B., Haapakoski, J., Rautalahti, M., Hartman, A., & Palmgren, J. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.6.1427s · Cited by 379
Tan, J.-A. (1997) · Molecular Endocrinology · doi:10.1210/me.11.4.450 · Cited by 375
Hellawell, G. O., Turner, G. D. H., Davies, D. R., Poulsom, R., BREWSTER, S. F., & Macaulay, V. M. (2002) · PubMed · Cited by 372
Shibata, A., Paganini-Hill, A., Ross, R., & Henderson, B. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.336 · Cited by 371
FOXO Proteins Regulate Tumor Necrosis Factor-related Apoptosis Inducing Ligand Expression
Modur, V., Nagarajan, R., Evers, B. M., & Milbrandt, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207509200 · Cited by 371
West, D. W., Slattery, M. L., Robison, L. M., French, T. K., & Mahoney, A. W. (1991) · Cancer Causes and Control · doi:10.1007/bf00053126 · Cited by 370
Matrilysin: An epithelial matrix metalloproteinase with potentially novel functions
Wilson, C. L., & Matrisian, L. M. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(95)00121-2 · Cited by 370
Berg, M. M., Sternberg, D. W., Parada, L. F., & Chao, M. V. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48447-5 · Cited by 369
LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis
Thalmann, G. N., Sikes, R. A., Wu, T. T., Degeorges, A., Chang, S.-M., Ozen, M., Pathak, S., & Chung, L. W. K. (2000) · The Prostate · doi:10.1002/1097-0045(20000701)44:2<91::aid-pros1>3.0.co;2-l · Cited by 366
Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford, P. A., Dodson, A. R., PARSONS, K. F., DESMOND, A. D., Woolfenden, A., Fordham, M., Neoptolemos, J. P., Ke, Y., & Foster, C. S. (2000) · PubMed · Cited by 365
Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.
Schwartz, G. G., Whitlatch, L. W., Chen, T. C., Lokeshwar, B. L., & Holick, M. F. (1998) · PubMed · Cited by 365
Effect of Alcohol (Ethanol) Administration on Sex-Hormone Metabolism in Normal Men
Gordon, G. G., Altman, K., Southren, A. L., Rubin, E., & Lieber, C. S. (1976) · New England Journal of Medicine · doi:10.1056/nejm197610072951501 · Cited by 364
Maroulakou, I. G., Anver, M., Garrett, L., & Green, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11236 · Cited by 363
INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVO
LIU, X. H., KIRSCHENBAUM, A., YAO, S., LEE, R., HOLLAND, J. F., & LEVINE, A. C. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67321-1 · Cited by 363
Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.
Gaddipati, J. P., McLeod, D. G. R., Heidenberg, H. B., Sesterhenn, I. A., Finger, M. J., Moul, J. W., & Srivastava, S. (1994) · PubMed · Cited by 363
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Bova, G. S., Carter, B. S., Bussemakers, M. J. G., Emi, M., Fujiwara, Y., Kyprianou, N., Jacobs, S. C., Robinson, J. C., Epstein, J. I., & Walsh, P. C. (1993) · PubMed · Cited by 363
p53 is mutated in a subset of advanced-stage prostate cancers.
Bookstein, R., MacGrogan, D., Hilsenbeck, S. G., Sharkey, F. E., & Allred, D. C. (1993) · PubMed · Cited by 362
Prospective Study of Plasma Fatty Acids and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Sacks, F. M., Grodstein, F., Giovannucci, E. L., & Stampfer, M. J. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.4.281 · Cited by 356
Vitamin D and prostate cancer: a prediagnostic study with stored sera.
Corder, E. H., Guess, H. A., Hulka, B. S., FRIEDMAN, G. D., Sadler, M. C., Vollmer, R. T., Lobaugh, B., Drezner, M. K., Vogelman∥, J. H., & Orentreich∥, N. (1993) · PubMed · Cited by 356
COHEN, P., PEEHL, D. M., LAMSON, G., & ROSENFELD, R. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-401 · Cited by 355
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
Thompson, T. C., Southgate, J., Kitchener, G., & Land, H. (1989) · Cell · doi:10.1016/0092-8674(89)90625-9 · Cited by 352
Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study.
Hsing, A. W., McLaughlin, J. K., Schuman, L. M., Bjelke, E., Gridley, G., Wacholder, S., Chien, H. T. C., & Blot, W. J. (1990) · PubMed · Cited by 348
NOBLE, R. L. (1977) · PubMed · Cited by 347
Hayward, S. W., Dahiya, R., Cunha, G. R., Bartek, J., Deshpande, N., & Narayan, P. (1995) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631333 · Cited by 340
Epidemiology of cancer of the prostate
Wynder, E. L., Mabuchi, K., & Whitmore, W. F. (1971) · Cancer · doi:10.1002/1097-0142(197108)28:2<344::aid-cncr2820280214>3.0.co;2-# · Cited by 338
Animal Fat Consumption and Prostate Cancer: A Prospective Study in Hawaii
Marchand, L. L., Kolonel, L. N., Wilkens, L. R., Myers, B. C., & Hirohata, T. (1994) · Epidemiology · doi:10.1097/00001648-199405000-00004 · Cited by 337
Peters, C. A., & Walsh, P. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709033171004 · Cited by 337
Influence of cytokine gene polymorphisms on the development of prostate cancer.
McCarron, S. L., Edwards, S. M., Evans, P. R., Gibbs, R., Dearnaley, D. P., Dowe, A., Southgate, C., Easton, D. F., Eeles, R. A., & Howell, W. M. (2002) · PubMed · Cited by 336
Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey, P. A., Zhu, X., Zarnegar, R., Swanson, P. E., Ratliff, T. L., Vollmer, R. T., & Day, M. L. (1995) · Europe PMC (PubMed Central) · Cited by 335
Interleukin-6 Is an Autocrine Growth Factor in Human Prostate Cancer
Giri, D., Ozen, M., & Ittmann, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63067-2 · Cited by 334
Socioeconomic Factors and Cancer Incidence Among Blacks and Whites
Baquet, C. R., Horm, J. W., Gibbs, T., & Greenwald, P. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.8.551 · Cited by 334
Genistein Chemoprevention: Timing and Mechanisms of Action in Murine Mammary and Prostate
Lamartiniere, C. A., Cotroneo, M. S., Fritz, W. A., Wang, J., Mentor-Marcel, R., & Elgavish, A. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.3.552s · Cited by 332
(1994) · PubMed Central · Cited by 328
Cunha, G. R. (1994) · Cancer · doi:10.1002/1097-0142(19940801)74:3+<1030::aid-cncr2820741510>3.0.co;2-q · Cited by 328
Tsihlias, J., Kapusta, L. R., Deboer, G., Morava-Protzner, I., Zbieranowski, I., Bhattacharya, N., Catzavelos, G. C., Lh, K., & Slingerland, J. (1998) · PubMed · Cited by 325
Geographic pathology of latent prostatic carcinoma
Yatani, R., Chigusa, I., Akazaki, K., Stemmermann, G. N., Welsh, R. A., & Correa, P. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910290602 · Cited by 325
Hebert, J. R., Hurley, T. G., Olendzki, B. C., Teas, J., Ma, Y., & Hampl, J. S. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1637 · Cited by 324
VCaP, a cell-based model system of human prostate cancer.
Korenchuk, S., Lehr, J. E., McLean, L. L., Lee, Y.-G., Whitney, S. C., Vessella, R. L., Lin, D. L., & Pienta, K. J. (2001) · PubMed · Cited by 323
Liao, S., Umekita, Y., Guo, J., Kokontis, J. M., & Hiipakka, R. A. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03948-v · Cited by 316
A systematic review and meta‐analysis of familial prostate cancer risk
Johns, L. E., & Houlston, R. S. (2003) · BJU International · doi:10.1046/j.1464-410x.2003.04232.x · Cited by 312
Physical activity and risk of cancer in the NHANES I population.
Albanes, D., Blair, A., & Taylor, P. R. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.6.744 · Cited by 312
Prooxidant-Antioxidant Shift Induced by Androgen Treatment of Human Prostate Carcinoma Cells
Ripple, M. O., Wilding, G., Henry, W. F., & Rago, R. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.1.40 · Cited by 309
Zinc Supplement Use and Risk of Prostate Cancer
Leitzmann, M. F., Stampfer, M. J., Wu, K., Colditz, G. A., Willett, W. C., & Giovannucci, E. L. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.1004 · Cited by 307
Jeronimo, C., Usadel, H., Henrique, R., Oliveira, J., Lopes, C., Nelson, W. G., & Sidransky, D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1747 · Cited by 306
Proximal location of mouse prostate epithelial stem cells
Tsujimura, A., Koikawa, Y., Salm, S., Takao, T., Coetzee, S., Moscatelli, D., Shapiro, E., Lepor, H., Sun, T.-T., & Wilson, E. L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202067 · Cited by 305
Richter, C., & Kass, G. E. N. (1991) · Chemico-Biological Interactions · doi:10.1016/0009-2797(91)90002-o · Cited by 301
Prostate Cancer: A Current Perspective
Nomura, A. M. Y., & Kolonel, L. N. (1991) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036069 · Cited by 301
Androgen receptor mutations in prostate cancer.
Barrack, E. R. (1996) · PubMed · Cited by 300
Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men.
Giovannucci, E. L., Pollak, M., Liu, Y., Platz, E. A., Majeed, N., Rimm, E. B., & Willett, W. C. (2003) · PubMed · Cited by 298
Heparin-binding keratinocyte growth factor is a candidate stromal-to- epithelial-cell andromedin
Yan, G. (1992) · Molecular Endocrinology · doi:10.1210/me.6.12.2123 · Cited by 294
Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia.
Emmert‐Buck, M. R., Vocke, C. D., Pozzatti, R., Duray, P. H., Jennings, S. B., Florence, C., Zhuang, Z., Bostwick, D. G., Liotta, L. A., & Linehan, W. M. (1995) · PubMed · Cited by 293
Self-citationDeletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma
Bergerheim, U. S. R., Kunimi, K., Collins, V. P., & Ekman, P. (1991) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870030308 · Cited by 290
Cunha, G. R., Fujii, H., Neubauer, B. L., Shannon, J. M., Sawyer, L., & Reese, B. A. (1983) · The Journal of cell biology · doi:10.1083/jcb.96.6.1662 · Cited by 287
Fatty fish consumption and risk of prostate cancer
Terry, P., Lichtenstein, P., Feychting, M., Ahlbom, A., & Wolk, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04889-3 · Cited by 284
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
Brooks, J. D., Weinstein, M. H., Lin, X., Sun, Y., Pin, S. S., Bova, G. S., Epstein, J. I., Isaacs, W. B., & Nelson, W. G. (1998) · PubMed · Cited by 282
Barrett-Connor, E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-807 · Cited by 281
BLUTE, M. L., BERGSTRALH, E. J., IOCCA, A., SCHERER, B., & ZINCKE, H. (2001) · Journal of Urology · doi:10.1097/00005392-200101000-00030 · Cited by 280
Serum Selenium and Subsequent Risk of Cancer Among Finnish Men and Women
Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R.-K., Hakama, M., Hakulinen, T., Peto, R., & Teppo, L. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.10.864 · Cited by 280
Dietary factors and risks for prostate cancer among blacks and whites in the United States.
Hayes, R. B., Ziegler, R. G., Gridley, G., Swanson, C., Greenberg, R. S., Swanson, G. M., Schoenberg, J. B., Silverman, D. T., Brown, L. M., Pottern, L. M., et al. (1999) · PubMed · Cited by 280
PERSONAL AND ENVIRONMENTAL CHARACTERISTICS RELATED TO EPITHELIAL OVARIAN CANCER
WHITTEMORE, A. S., WU, M. L., PAFFENBARGER, R. S., SARLES, D. L., KAMPERT, J. B., GROSSER, S., JUNG, D. L., BALLON, S., & HENDRICKSON, M. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115077 · Cited by 279
Ferrer, F. A., Miller, L. J., Andrawis, R. I., Kurtzman, S. H., Albertsen, P. C., Laudone, V. P., & Kreutzer, D. L. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64775-x · Cited by 278
Plant Foods, Antioxidants, and Prostate Cancer Risk: Findings From Case-Control Studies in Canada
Jain, M. G., Hislop, G. T., Howe, G. R., & Ghadirian, P. (1999) · Nutrition and Cancer · doi:10.1207/s15327914nc3402_8 · Cited by 276
Meta-Analysis of Measures of Sexual Activity and Prostate Cancer
Dennis, L. K., & Dawson, D. V. (2002) · Epidemiology · doi:10.1097/00001648-200201000-00012 · Cited by 274
Pienta, K. J., Nailk, H., Akhtar, A., Yamazaki, K., Replogle, T. S., Lehr, J., Donat, T. L., Tait, L., Hogan, V., & Raz, A. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.5.348 · Cited by 272
DIET AND PROSTATIC CANCER: A CASE-CONTROL STUDY IN HAWAII1
KOLONEL, L. N., YOSHIZAWA, C. N., & HANKIN, J. H. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114903 · Cited by 270
Bostwick, D. G., Alexander, E. E., Singh, R., Shan, A., Qian, J., Santella, R. M., Oberley, L. W., Yan, T., Zhong, W., Jiang, X., et al. (2000) · Cancer · doi:10.1002/1097-0142(20000701)89:1<123::aid-cncr17>3.0.co;2-9 · Cited by 269
Self-citationDong, J., Suzuki, H., Pin, S. S., Bova, G. S., Schalken, J. A., Isaacs, W. B., Barrett, J. C., & Isaacs, J. T. (1996) · PubMed · Cited by 269
C-met Proto-Oncogene Expression in Benign and Malignant Human Prostate Tissues
Pisters, L. L., Troncoso, P., Zhau, H. E., Li, W., von Eschenbach, A. C., & Chung, L. W. K. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)67297-5 · Cited by 269
Zinc in the human prostate gland: Normal, hyperplastic and cancerous
Zaichick, V. Y., Sviridova, T. V., & Zaichick, S. V. (1997) · International Urology and Nephrology · doi:10.1007/bf02552202 · Cited by 265
Interleukin-6 and prostate cancer progression
SMITH, P., HOBISCH, A., LIN, D., CULIG, Z., & KELLER, E. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00021-6 · Cited by 264
Swinnen, J. V., Ulrix, W., Heyns, W., & Verhoeven, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.12975 · Cited by 262
Shariat, S. F., Andrews, B., Kattan, M. W., Kim, J., Wheeler, T. M., & Slawin, K. M. (2001) · Urology · doi:10.1016/s0090-4295(01)01405-4 · Cited by 261
Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey
Dosemeci, M., Hayes, R. B., Vetter, R., Hoover, R. N., Tucker, M., Engin, K., Unsal, M., & Blair, A. (1993) · Cancer Causes and Control · doi:10.1007/bf00051333 · Cited by 260
Physical activity and incidence of cancer in diverse populations: a preliminary report
Paffenbarger, R. S., Hyde, R. T., & Wing, A. L. (1987) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/45.1.312 · Cited by 259
Age and Racial Distribution of Prostatic Intraepithelial Neoplasia
Sakr, W., Grignon, D. J., Haas, G. P., Heilbrun, L. K., Pontes, J. E., & Crissmana, J. D. (1996) · European Urology · doi:10.1159/000474163 · Cited by 258
Decrease and Gain of Gene Expression Are Equally Discriminatory Markers for Prostate Carcinoma
Ernst, T., Hergenhahn, M., Kenzelmann, M., Cohen, C. D., Bonrouhi, M., Weninger, A., Klären, R., Gröne, E. F., Wiesel, M., Güdemann, C., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61165-0 · Cited by 258
Barnes, S., Peterson, T. G., & Coward, L. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590823 · Cited by 257
Platz, E. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.2009 · Cited by 255
Research works printed but not linked: 902
- Oishi, 1995, Cancer Surv., 23, 267
- Parkin, 1992, IARC Sci Publ., 120, 45
- Doherty, 1996, Br J Hosp Med., 55, 104
- Morrison, 1995, Can J Public Health., 86, 274
- Dijkman, 1996, Eur Urol., 30, 281, 10.1159/000474185 · doi:10.1159/000474185
- Wingo, 1998, Cancer Epidemiol Biomarkers Prev., 7, 271
- Merrill, 1996, J Natl Cancer Inst., 88, 1683, 10.1093/jnci/88.22.1683 · doi:10.1093/jnci/88.22.1683
- Mettlin, 1996, Cancer., 77, 150, 10.1002/(SICI)1097-0142(19960101)77:1<150::AID-CNCR25>3.0.CO;2-3 · doi:10.1002/(sici)1097-0142(19960101)77:1<150::aid-cncr25>3.0.co;2-3
- Brawley, 1997, Cancer., 80, 1857, 10.1002/(SICI)1097-0142(19971101)80:9<1857::AID-CNCR26>3.0.CO;2-3 · doi:10.1002/(sici)1097-0142(19971101)80:9<1857::aid-cncr26>3.0.co;2-3
- Wingo, 1997, Cancer., 80, 1810, 10.1002/(SICI)1097-0142(19971101)80:9<1810::AID-CNCR19>3.0.CO;2-8 · doi:10.1002/(sici)1097-0142(19971101)80:9<1810::aid-cncr19>3.0.co;2-8
- Levy, 1993, CMAJ., 149, 617
- Smart, 1997, CA Cancer J Clin., 47, 134, 10.3322/canjclin.47.3.134 · doi:10.3322/canjclin.47.3.134
- Pienta, 1995, Urology., 45, 93, 10.1016/S0090-4295(95)96996-9 · doi:10.1016/s0090-4295(95)96996-9
- Dhom, 1983, J Cancer Res Clin Oncol., 106, 210, 10.1007/BF00402610 · doi:10.1007/bf00402610
- Polednak, 1997, Cancer., 79, 99, 10.1002/(SICI)1097-0142(19970101)79:1<99::AID-CNCR14>3.0.CO;2-1 · doi:10.1002/(sici)1097-0142(19970101)79:1<99::aid-cncr14>3.0.co;2-1
- Newman, 1996, Radiol Technol., 68, 39
- Bostwick, 1992, Cancer., 70, 291, 10.1002/1097-0142(19920701)70:1+<291::AID-CNCR2820701317>3.0.CO;2-4 · doi:10.1002/1097-0142(19920701)70:1+<291::aid-cncr2820701317>3.0.co;2-4
- Partin, 1994, Urology., 44, 646, 10.1016/S0090-4295(94)80197-5 · doi:10.1016/s0090-4295(94)80197-5
- Bostwick, 2000, Curr Urol Rep., 1, 65, 10.1007/s11934-000-0037-x · doi:10.1007/s11934-000-0037-x
- Bostwick, 1987, Cancer., 59, 788, 10.1002/1097-0142(19870215)59:4<788::AID-CNCR2820590421>3.0.CO;2-I · doi:10.1002/1097-0142(19870215)59:4<788::aid-cncr2820590421>3.0.co;2-i
- Montironi, 1996, Eur Urol., 30, 133, 10.1159/000474162 · doi:10.1159/000474162
- Allam, 1996, Mod Pathol., 9, 742
- Qian, 1997, Hum Pathol., 28, 143, 10.1016/S0046-8177(97)90097-6 · doi:10.1016/s0046-8177(97)90097-6
- Feneley, 1997, Prostate Cancer Prostatic Dis., 1, 79, 10.1038/sj.pcan.4500210 · doi:10.1038/sj.pcan.4500210
- Sakr, 1997, Eur Urol., 32, 15
- Keetch, 1995, J Urol., 154, 347, 10.1016/S0022-5347(01)67044-7 · doi:10.1016/s0022-5347(01)67044-7
- Raviv, 1996, Acta Urol Belgium., 64, 11
- Rovner, 1997, J Urol., 158, 138, 10.1097/00005392-199707000-00042 · doi:10.1097/00005392-199707000-00042
- Davidson, 1995, J Urol., 154, 1295, 10.1016/S0022-5347(01)66840-X · doi:10.1016/s0022-5347(01)66840-x
- Shepherd, 1996, J Urol., 156, 460, 10.1016/S0022-5347(01)65881-6 · doi:10.1016/s0022-5347(01)65881-6
- Langer, 1996, J Urol., 155, 228, 10.1016/S0022-5347(01)66601-1 · doi:10.1016/s0022-5347(01)66601-1
- Bostwick, 1996, Eur Urol., 30, 145, 10.1159/000474164 · doi:10.1159/000474164
- Bostwick, 1996, Cancer., 78, 330, 10.1002/(SICI)1097-0142(19960715)78:2<330::AID-CNCR22>3.0.CO;2-W · doi:10.1002/(sici)1097-0142(19960715)78:2<330::aid-cncr22>3.0.co;2-w
- Ferguson, 1994, Urology., 44, 91, 10.1016/S0090-4295(94)80015-4 · doi:10.1016/s0090-4295(94)80015-4
- Aquilina, 1997, J Natl Cancer Inst., 89, 689, 10.1093/jnci/89.10.689 · doi:10.1093/jnci/89.10.689
- Colombel, 1993, Am J Pathol., 143, 390
- Goldstein, 1995, Hum Pathol., 26, 887, 10.1016/0046-8177(95)90012-8 · doi:10.1016/0046-8177(95)90012-8
- Saez, 1998, Mod Pathol., 11, 1193
- Papadopoulos, 2001, Clin Cancer Res., 7, 1533
- Kirschenbaum, 1999, Mol Urol., 3, 163
- Molberg, 1994, Am J Clin Pathol., 101, 266, 10.1093/ajcp/101.3.266 · doi:10.1093/ajcp/101.3.266
- Shah, 2001, Arch Pathol Lab Med., 125, 141, 10.5858/2001-125-0141-HAHCOS · doi:10.5858/2001-125-0141-hahcos
- Bostwick, 1995, Arch Pathol Lab Med., 119, 444
- Varma, 2002, Arch Pathol Lab Med., 126, 554, 10.5858/2002-126-0554-MCFTDO · doi:10.5858/2002-126-0554-mcftdo
- Egan, 1997, Am J Surg Pathol., 21, 931, 10.1097/00000478-199708000-00007 · doi:10.1097/00000478-199708000-00007
- Zhou, 2001, Am J Clin Pathol., 115, 39, 10.1309/2APJ-YKBD-97EH-67GW · doi:10.1309/2apj-ykbd-97eh-67gw
- Bonin, 1997, Cancer., 79, 75, 10.1002/(SICI)1097-0142(19970101)79:1<75::AID-CNCR11>3.0.CO;2-3 · doi:10.1002/(sici)1097-0142(19970101)79:1<75::aid-cncr11>3.0.co;2-3
- Ozcan, 2001, Eur Urol., 40, 308, 10.1159/000049791 · doi:10.1159/000049791
- D'Amico, 2001, J Urol., 165, 126, 10.1097/00005392-200101000-00031 · doi:10.1097/00005392-200101000-00031
- Nelson, 2002, Urology., 59, 740, 10.1016/S0090-4295(02)01654-0 · doi:10.1016/s0090-4295(02)01654-0
- O'Malley, 2002, Urology., 59, 85, 10.1016/S0090-4295(01)01486-8 · doi:10.1016/s0090-4295(01)01486-8
- Freedland, 2002, J Urol., 167, 516, 10.1016/S0022-5347(01)69076-1 · doi:10.1016/s0022-5347(01)69076-1
- Sebo, 2001, Cancer., 91, 2196, 10.1002/1097-0142(20010601)91:11<2196::AID-CNCR1249>3.0.CO;2-# · doi:10.1002/1097-0142(20010601)91:11<2196::aid-cncr1249>3.0.co;2-#
- Merrick, 2002, Cancer J., 8, 79, 10.1097/00130404-200201000-00014 · doi:10.1097/00130404-200201000-00014
- Bahnson, 1989, Prostate., 15, 149, 10.1002/pros.2990150208 · doi:10.1002/pros.2990150208
- Montironi, 1993, Virchows Arch A Pathol Anat Histopathol., 422, 185, 10.1007/BF01621801 · doi:10.1007/bf01621801
- Weidner, 1993, Am J Pathol., 143, 401
- Brawer, 1994, Cancer., 73, 678, 10.1002/1097-0142(19940201)73:3<678::AID-CNCR2820730329>3.0.CO;2-6 · doi:10.1002/1097-0142(19940201)73:3<678::aid-cncr2820730329>3.0.co;2-6
- Hall, 1994, Urology., 44, 869, 10.1016/S0090-4295(94)80173-8 · doi:10.1016/s0090-4295(94)80173-8
- Vesalainen, 1994, Anticancer Res., 14, 709
- Epstein, 2000, Urology., 56, 283, 10.1016/S0090-4295(00)00640-3 · doi:10.1016/s0090-4295(00)00640-3
- Silberman, 1997, Cancer., 79, 772, 10.1002/(SICI)1097-0142(19970215)79:4<772::AID-CNCR14>3.0.CO;2-X · doi:10.1002/(sici)1097-0142(19970215)79:4<772::aid-cncr14>3.0.co;2-x
- de la Taille, 2000, Am J Clin Pathol., 113, 555, 10.1309/02W2-KE50-PKEF-G2G4 · doi:10.1309/02w2-ke50-pkef-g2g4
- Stamey, 1999, JAMA., 281, 1395, 10.1001/jama.281.15.1395 · doi:10.1001/jama.281.15.1395
- van den Ouden, 1998, Urol Int., 60, 17, 10.1159/000030197 · doi:10.1159/000030197
- McNeal, 1996, Am J Surg Pathol., 20, 1351, 10.1097/00000478-199611000-00006 · doi:10.1097/00000478-199611000-00006
- Mehta, 2001, Clin Cancer Res., 7, 81
- Whittemore, 1995, Am J Epidemiol., 141, 732, 10.1093/oxfordjournals.aje.a117495 · doi:10.1093/oxfordjournals.aje.a117495
- Klein, 1998, Prostate Cancer Prostatic Dis., 1, 297, 10.1038/sj.pcan.4500257 · DOI
- Damber, 1998, Int J Cancer., 78, 293, 10.1002/(SICI)1097-0215(19981029)78:3<293::AID-IJC5>3.0.CO;2-Q · doi:10.1002/(sici)1097-0215(19981029)78:3<293::aid-ijc5>3.0.co;2-q
- Bratt, 1999, Eur J Cancer., 35, 272, 10.1016/S0959-8049(98)00358-X · doi:10.1016/s0959-8049(98)00358-x
- Cerhan, 1999, Cancer Epidemiol Biomarkers Prev., 8, 53
- Lightfoot, 2000, Ann Epidemiol., 10, 470, 10.1016/S1047-2797(00)00112-5 · doi:10.1016/s1047-2797(00)00112-5
- Kalish, 2000, Urology., 56, 803, 10.1016/S0090-4295(00)00780-9 · DOI
- Kotsis, 2002, J Urol., 167, 1659, 10.1016/S0022-5347(05)65173-7 · doi:10.1016/s0022-5347(05)65173-7
- Cotter, 2002, Prostate., 50, 216, 10.1002/pros.10051 · doi:10.1002/pros.10051
- Stone, 2003, Ethn Dis., 13, 233
- Gronberg, 1999, Cancer., 86, 477, 10.1002/(SICI)1097-0142(19990801)86:3<477::AID-CNCR16>3.0.CO;2-K · doi:10.1002/(sici)1097-0142(19990801)86:3<477::aid-cncr16>3.0.co;2-k
- Schuurman, 1999, Epidemiology., 10, 192, 10.1097/00001648-199903000-00020 · doi:10.1097/00001648-199903000-00020
- McLellan, 1995, CMAJ., 153, 895
- Staples, 2003, Cancer Causes Control., 14, 161, 10.1023/A:1023073203467 · doi:10.1023/a:1023073203467
- Matikainen, 1999, Clin Cancer Res., 5, 1275
- Thiessen, 1974, Cancer., 34, 1102, 10.1002/1097-0142(197410)34:4<1102::AID-CNCR2820340421>3.0.CO;2-5 · doi:10.1002/1097-0142(197410)34:4<1102::aid-cncr2820340421>3.0.co;2-5
- Anderson, 1992, J Natl Cancer Inst., 84, 1114, 10.1093/jnci/84.14.1114 · doi:10.1093/jnci/84.14.1114
- Andrieu, 1991, Eur J Cancer., 27, 244, 10.1016/0277-5379(91)90506-9 · doi:10.1016/0277-5379(91)90506-9
- Henderson, 1982, Cancer Res., 42, 3232
- Ghanadian, 1979, Br J Cancer., 39, 696, 10.1038/bjc.1979.122 · doi:10.1038/bjc.1979.122
- Vatten, 1997, Cancer Epidemiol Biomarkers Prev., 6, 967
- Nomura, 1996, Cancer Epidemiol Biomarkers Prev., 5, 621
- Guess, 1997, Cancer Epidemiol Biomarkers Prev., 6, 21
- Chang, 2001, Prostate., 46, 62, 10.1002/1097-0045(200101)46:1<62::AID-PROS1009>3.0.CO;2-V · doi:10.1002/1097-0045(200101)46:1<62::aid-pros1009>3.0.co;2-v
- Stattin, 2001, J Clin Endocrinol Metab., 86, 1341
- Ross, 1986, J Natl Cancer Inst., 76, 45
- Barrett-Connor, 1990, Cancer Res., 50, 169
- Jackson, 1981, Progr Clin Biol Res., 53, 111
- Modugno, 2001, Clin Cancer Res., 7, 3092
- Haenszel, 1968, J Natl Cancer Inst., 40, 43
- Locke, 1980, J Natl Cancer Inst., 65, 1149
- Stellman, 1994, Cancer., 73, 1270, 10.1002/1097-0142(19940215)73:4<1270::AID-CNCR2820730423>3.0.CO;2-Y · doi:10.1002/1097-0142(19940215)73:4<1270::aid-cncr2820730423>3.0.co;2-y
- Merrill, 2000, Urology., 55, 730, 10.1016/S0090-4295(99)00564-6 · doi:10.1016/s0090-4295(99)00564-6
- Abdalla, 1998, Semin Urol Oncol., 16, 207
- Asbell, 2000, J Natl Med Assoc., 92, 445
- Zhang, 2000, J Urol., 163, 131, 10.1016/S0022-5347(05)67988-8 · doi:10.1016/s0022-5347(05)67988-8
- Fowler, 2000, J Urol., 163, 1467, 10.1016/S0022-5347(05)67644-6 · doi:10.1016/s0022-5347(05)67644-6
- Wu, 2001, Cancer Epidemiol Biomarkers Prev., 10, 533
- Reichardt, 1995, Cancer Res., 55, 3973
- Platz, 1999, Cancer Epidemiol Biomarkers Prev., 8, 1107
- Winter, 2001, Urology., 58, 614, 10.1016/S0090-4295(01)01273-0 · doi:10.1016/s0090-4295(01)01273-0
- Ekman, 1999, Prostate., 39, 262, 10.1002/(SICI)1097-0045(19990601)39:4<262::AID-PROS6>3.0.CO;2-P · doi:10.1002/(sici)1097-0045(19990601)39:4<262::aid-pros6>3.0.co;2-p
- Corder, 1995, Cancer Epidemiol Biomarkers Prev., 4, 655
- Yamada, 2001, Int J Cancer., 92, 683, 10.1002/1097-0215(20010601)92:5<683::AID-IJC1255>3.0.CO;2-4 · doi:10.1002/1097-0215(20010601)92:5<683::aid-ijc1255>3.0.co;2-4
- Leadon, 1990, Health Phys., 59, 15, 10.1097/00004032-199007000-00001 · doi:10.1097/00004032-199007000-00001
- Statland, 1992, Clin Chem., 38, 1587
- Palmiter, 1987, Experientia., 52, 63
- Yu, 1994, Cancer., 73, 596, 10.1002/1097-0142(19940201)73:3<596::AID-CNCR2820730316>3.0.CO;2-N · doi:10.1002/1097-0142(19940201)73:3<596::aid-cncr2820730316>3.0.co;2-n
- Hietanen, 1994, Eur J Clin Nutr., 48, 575
- Hietanen, 1991, Carcinogenesis., 12, 591, 10.1093/carcin/12.4.591 · doi:10.1093/carcin/12.4.591
- Clark, 1996, JAMA., 276, 1957, 10.1001/jama.1996.03540240035027 · DOI · Paper page
- Han, 1995, Carcinogenesis., 16, 951, 10.1093/carcin/16.4.951 · doi:10.1093/carcin/16.4.951
- Schuurman, 1999, Cancer., 86, 1019, 10.1002/(SICI)1097-0142(19990915)86:6<1019::AID-CNCR18>3.0.CO;2-H · doi:10.1002/(sici)1097-0142(19990915)86:6<1019::aid-cncr18>3.0.co;2-h
- Berg, 1975, Cancer Res., 35, 3345
- Blair, 1978, J Natl Cancer Inst., 61, 1379
- Ohno, 1988, Cancer Res., 48, 1331
- Mettlin, 1989, Cancer., 64, 605, 10.1002/1097-0142(19890801)64:3<605::AID-CNCR2820640307>3.0.CO;2-I · doi:10.1002/1097-0142(19890801)64:3<605::aid-cncr2820640307>3.0.co;2-i
- Hayes, 1999, Cancer Epidemiol Biomarkers Prev., 8, 25
- Graham, 1983, J Natl Cancer Inst., 70, 687
- Ross, 1987, J Natl Cancer Inst., 78, 869
- Severson, 1989, Cancer Res., 49, 1857
- Mills, 1989, Cancer., 64, 598, 10.1002/1097-0142(19890801)64:3<598::AID-CNCR2820640306>3.0.CO;2-6 · doi:10.1002/1097-0142(19890801)64:3<598::aid-cncr2820640306>3.0.co;2-6
- Hirayama, 1979, Natl Cancer Inst Monogr., 53, 149
- Hsing, 1990, Cancer Res., 50, 6836
- De Stefani, 2000, Cancer Epidemiol Biomarkers Prev., 9, 335
- Harvei, 1997, Int J Cancer., 71, 545, 10.1002/(SICI)1097-0215(19970516)71:4<545::AID-IJC7>3.0.CO;2-U · doi:10.1002/(sici)1097-0215(19970516)71:4<545::aid-ijc7>3.0.co;2-u
- Bishop, 1988, Immunogenetics., 28, 184, 10.1007/BF00375858 · doi:10.1007/bf00375858
- Sporn, 1984, J Natl Cancer Inst., 73, 1381
- Kummet, 1983, Semin Oncol., 10, 281
- Olsen, 1996, Ugeskr Laeger., 158, 3171
- Kolonel, 1987, Cancer Res., 47, 2982
- Ellison, 1998, Chron Dis Can., 19, 1
- Paganini-Hill, 1987, J Natl Cancer Inst., 79, 443
- Hayes, 1988, Cancer., 62, 2021, 10.1002/1097-0142(19881101)62:9<2021::AID-CNCR2820620925>3.0.CO;2-R · doi:10.1002/1097-0142(19881101)62:9<2021::aid-cncr2820620925>3.0.co;2-r
- Reichman, 1990, Cancer Res., 50, 2311
- Wald, 1986, Br J Cancer., 54, 957, 10.1038/bjc.1986.267 · doi:10.1038/bjc.1986.267
- Nomura, 1997, Cancer Epidemiol Biomarkers Prev., 6, 487
- Cook, 1999, Cancer., 86, 1783, 10.1002/(SICI)1097-0142(19991101)86:9<1783::AID-CNCR21>3.0.CO;2-N · doi:10.1002/(sici)1097-0142(19991101)86:9<1783::aid-cncr21>3.0.co;2-n
- Lu, 2001, Cancer Epidemiol Biomarkers Prev., 10, 749
- Hirayama, 1986, Gan No Rinsho., 32, 610
- Clinton, 1999, Cancer., 86, 1629, 10.1002/(SICI)1097-0142(19991101)86:9<1629::AID-CNCR1>3.0.CO;2-4 · doi:10.1002/(sici)1097-0142(19991101)86:9<1629::aid-cncr1>3.0.co;2-4
- Eichholzer, 1999, Prostate., 38, 189, 10.1002/(SICI)1097-0045(19990215)38:3<189::AID-PROS3>3.0.CO;2-N · doi:10.1002/(sici)1097-0045(19990215)38:3<189::aid-pros3>3.0.co;2-n
- Schwartz, 1990, Anticancer Res., 10, 1307
- Corder, 1993, Cancer Epidemiol Biomarkers Prev., 2, 467
- Peehl, 1999, Eur Urol., 35, 392, 10.1159/000019914 · doi:10.1159/000019914
- Suzuki, 2003, Int J Urol., 10, 261, 10.1046/j.1442-2042.2003.00617.x · doi:10.1046/j.1442-2042.2003.00617.x
- Schwartz, 1998, Cancer Epidemiol Biomarkers Prev., 7, 391
- Gann, 1996, Cancer Epidemiol Biomarkers Prev., 5, 121
- Schwartz, 1994, Anticancer Res., 14, 1077
- Chan, 1999, Cancer Epidemiol Biomarkers Prev., 8, 893
- Liang, 1999, Prostate., 40, 200, 10.1002/(SICI)1097-0045(19990801)40:3<200::AID-PROS8>3.0.CO;2-3 · doi:10.1002/(sici)1097-0045(19990801)40:3<200::aid-pros8>3.0.co;2-3
- Feustel, 1986, Prostate., 8, 75, 10.1002/pros.2990080109 · doi:10.1002/pros.2990080109
- Leake, 1984, Acta Endocrinol (Copenhagen)., 105, 281, 10.1530/acta.0.1050281 · doi:10.1530/acta.0.1050281
- Whelan, 1983, Br J Urol., 55, 525, 10.1111/j.1464-410X.1983.tb03362.x · doi:10.1111/j.1464-410x.1983.tb03362.x
- Chirulescu, 1987, Med Interne., 25, 257
- Ogunlewe, 1989, Cancer., 63, 1388, 10.1002/1097-0142(19890401)63:7<1388::AID-CNCR2820630725>3.0.CO;2-M · doi:10.1002/1097-0142(19890401)63:7<1388::aid-cncr2820630725>3.0.co;2-m
- Lekili, 1991, Int Urol Nephrol., 23, 151, 10.1007/BF02549712 · doi:10.1007/bf02549712
- McCallum, 1988, Br J Urol., 62, 565, 10.1111/j.1464-410X.1988.tb04427.x · doi:10.1111/j.1464-410x.1988.tb04427.x
- Feustel, 1989, Urol Res., 17, 41
- Tvedt, 1989, Prostate., 15, 41, 10.1002/pros.2990150105 · doi:10.1002/pros.2990150105
- Elghany, 1990, Epidemiology., 1, 107, 10.1097/00001648-199003000-00005 · doi:10.1097/00001648-199003000-00005
- Goodman, 2001, Cancer Epidemiol Biomarkers Prev., 10, 1069
- Nomura, 2000, Cancer Epidemiol Biomarkers Prev., 9, 883
- Grant, 1999, Altern Med Rev., 4, 162
- Rodriguez, 2003, Cancer Epidemiol Biomarkers Prev., 12, 597
- Balaji, 2001, Prostate., 48, 265, 10.1002/pros.1106 · doi:10.1002/pros.1106
- Sung, 1999, Cancer., 86, 484, 10.1002/(SICI)1097-0142(19990801)86:3<484::AID-CNCR17>3.0.CO;2-P · doi:10.1002/(sici)1097-0142(19990801)86:3<484::aid-cncr17>3.0.co;2-p
- Hsieh, 1999, Int J Cancer., 80, 699, 10.1002/(SICI)1097-0215(19990301)80:5<699::AID-IJC12>3.0.CO;2-7 · doi:10.1002/(sici)1097-0215(19990301)80:5<699::aid-ijc12>3.0.co;2-7
- van der Gulden, 1994, Br J Urol., 73, 382, 10.1111/j.1464-410X.1994.tb07601.x · doi:10.1111/j.1464-410x.1994.tb07601.x
- Kolonel, 1977, Lancet., 2, 566, 10.1016/S0140-6736(77)90714-0 · doi:10.1016/s0140-6736(77)90714-0
- Schuman, 1977, Cancer Treat Rep., 61, 181
- Niijima, 1980, Scand J Urol Nephrol., 55, 177
- Newell, 1998, Vet Radiol Ultrasound., 39, 332, 10.1111/j.1740-8261.1998.tb01616.x · doi:10.1111/j.1740-8261.1998.tb01616.x
- Talamini, 1993, Prev Med., 22, 400, 10.1006/pmed.1993.1033 · doi:10.1006/pmed.1993.1033
- Hayes, 1994, Cancer Causes Control., 5, 221, 10.1007/BF01830240 · doi:10.1007/bf01830240
- Lumey, 1997, Prostate., 33, 195, 10.1002/(SICI)1097-0045(19971101)33:3<195::AID-PROS8>3.0.CO;2-I · doi:10.1002/(sici)1097-0045(19971101)33:3<195::aid-pros8>3.0.co;2-i
- Giles, 2001, Ann Oncol., 12, 761, 10.1023/A:1011131105617 · doi:10.1023/a:1011131105617
- Plaskon, 2003, Cancer Epidemiol Biomarkers Prev., 12, 604
- Lotufo, 2000, Int J Cancer., 87, 141, 10.1002/1097-0215(20000701)87:1<141::AID-IJC21>3.0.CO;2-A · doi:10.1002/1097-0215(20000701)87:1<141::aid-ijc21>3.0.co;2-a
- Whittemore, 1985, J Natl Cancer Inst., 74, 43
- Carstensen, 1987, J Epidemiol Commun Health., 41, 166, 10.1136/jech.41.2.166 · DOI
- Giovannucci, 1999, Cancer Epidemiol Biomarkers Prev., 8, 277
- Colditz, 1996, Cancer Causes Control., 7, 560, 10.1007/BF00051890 · doi:10.1007/bf00051890
- Yu, 1997, Cancer Detect Prev., 21, 497
- Verhoeven, 1996, Cancer Epidemiol Biomarkers Prev., 5, 733
- Schuurman, 1998, Cancer Epidemiol Biomarkers Prev., 7, 673
- Kolonel, 2000, Cancer Epidemiol Biomarkers Prev., 9, 795
- Lee, 2003, Cancer Epidemiol Biomarkers Prev., 12, 665
- Gann, 1999, Cancer Res., 59, 1225
- Clinton, 1996, Cancer Epidemiol Biomarkers Prev., 5, 823
- Imaida, 2001, Carcinogenesis., 22, 467, 10.1093/carcin/22.3.467 · doi:10.1093/carcin/22.3.467
- Watson, 1995, Environ Health Perspect., 103, 41
- Soto, 1995, Environ Health Perspect., 103, 113
200 of 902 shown
Cited by
Epidemiology of Prostate Cancer
Rawla, P. (2019) · World Journal of Oncology · doi:10.14740/wjon1191 · Cited by 2,776
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, I. M., Ankerst, D. P., Chi, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj131 · Cited by 938
Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies
Hormones, E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm323 · Cited by 786
Tang, W.-Y., Morey, L. M., Cheung, Y. Y., Birch, L., Prins, G. S., & Ho, S.-M. (2012) · Endocrinology · doi:10.1210/en.2011-1308 · Cited by 164
Self-citationBarrington, W. E., Schenk, J. M., Etzioni, R., Arnold, K. B., Neuhouser, M. L., Thompson, I. M., Lucia, M. S., & Kristal, A. R. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0513 · Cited by 107
Metadata
- Authors
- Bostwick, D. G., Burke, H. B., Djakiew, D., Euling, S., Ho, S.-M., Landolph, J., Morrison, H., Sonawane, B., Shifflett, T., Waters, D. J., & Timms, B.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2004
- Volume
- 101
- Issue
- S10
- Pages
- 2371-2490
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2121518362
- Cited by
- 650
- References
- 914
- FWCI
- 18.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 4261 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.